615
All developed mucocutaneous side effects within 20 weeks of beginning im gold therapy, at a time when RA had improved markedly compared to pretreatment status.
 mucocutaneous side effects: Effect; im gold therapy: Treatment; gold: Treatment.Drug; im: Treatment.Route; within 20 weeks: Treatment.Time_elapsed; RA: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 mucocutaneous side effects: Effect; im gold therapy: Treatment; gold: Treatment.Drug; im: Treatment.Route; within 20 weeks: Treatment.Time_elapsed; RA: Treatment.Disorder